About Predimed
Based in Strasbourg, France, Predimed Technology is a startup specialized in medical monitoring services created in 2017. We offer telemedicine solutions based on innovative artificial intelligence technologies to improve the quality of life of patients.
The company’s ambition is to enable the modeling of new care pathways that put the patient at the center of concerns. We have become aware of the importance of providing a response that integrates both the technical and social dimensions to combat medical deserts and patient isolation in order to help them understand and manage their diseases. Our first product is My Predi, the intelligent remote medical monitoring platform for people with chronic diseases. The intelligent platform detects situations at risk of hospitalization at an early stage, with the aim of preventing them.
Our My Predi home monitoring service is therefore based on new technologies and connected objects in order to support the medical profession in caring for their patients. Resulting from a collaboration between industrialists, scientists and doctors, the My Predi platform was awarded in 2012 the Future Investment in e-Health programme for the development of digital services for health and autonomy, and in 2015 the Fondation de l’Avenir prize. In 2017, the InterPros trophy was awarded to it by the Academy of Medicine.
Over the years, Predimed has acquired expertise in the field of remote monitoring thanks to multiple experiments.
CEO of Predimed Technology
“After completing a doctorate in Networks and Telecommunications in Strasbourg in 1989, I joined the Alcatel Group to work in the PABX and integration of TCP/IP protocols into telephone systems division. Before joining the Carrier Networking Group in Anvers to manage the development and manufacture of the first Wifi in the world ADSL routers, I led a research group in Marcoussis on the topic of Home Networking. This was the beginning of today’s Smart Homes. After this extensive industry experience, I spent 6 years working for an insurance group that has now become GENERALI running strategic telecoms projects. That enabled me to gain extensive experience in users of Telecoms tools. After that, I co-founded and managed the company NEWEL where I set up an effective management team so I could focus on large-scale missions and bringing innovative solutions in computing and e-health to market.
For 6 years, I was involved in the development of telemedicine in France through several projects, notably in collaboration with the Hospitals of Strasbourg. I gained considerable experience in the world of telemedicine through projects such as E-care, winner of the PIA 2012, that I was involved in for 3 years.
PREDIMED Technology is the result of all these years of experience acquired in the field of telemedicine.”
The Team
The Predimed Technology team is made up of young and dynamic people who share the same mission: to improve the medical care of patients by proposing intelligent and innovative models for tomorrow’s medicine.
Experienced technicians, engineers and IT developers offer 360° expertise for a constant and continuous improvement of the personalized connected care pathway.
Lucie Esteoulle
Telemedicine Project Manager
Didier Yao Coutouclui
IT Developer
Houda Habbita
Marketing and Communication Manager
Abdou Dia
IT Developer
The Scientific Committee
In order to offer solutions that meet patients’ needs, we asked healthcare professionals and telemedicine experts to share their vision of the future of medicine with us. We have formed a multidisciplinary scientific council at the crossroads of digital and health.
It is composed of medical experts recognized in their specific field. This group of experts remains totally independent from PREDIMED Technology and assists the president in his strategic choices. This group of scientific advisers evolves over the years and the strategic trends defined by PREDIMED Technology.
This board meets 2 to 3 times a year to exchange on scientific activities and to define research axes that take into account the dynamics of the health market in France and Europe. In the same way, the scientific council validates the state of scientific knowledge on the identified issues and gives an opinion on the work carried out.
Today, we have the honour of being accompanied by leading experts in the field of telemedicine:
A real driving force for the development of knowledge and the E-care medical strategy, Professor Emmanuel Andrès has over 20 years’ experience in Internal Medicine.
Head of the Department of Internal Medicine, Diabetes and Metabolic Diseases at the University Hospital of Strasbourg where he served as Chair of the Scientific Committee, Professor Andrès is also involved in clinical research on systemic diseases and haematology, auto-immune disorders, heart failure, as well as vitamin B12 deficiency.
In terms of education, Professor Andrès is Chairman of the Department of Continuing Medical Education, Faculty of Medicine and is an active member of the Laboratory for Research in Pedagogy of the Health Sciences.
A recognised expert in diabetes, Professor Nathalie Jeandidier develops knowledge on diabetes for the E-care platform. Director of the Department of Endocrinology, Diabetes and Metabolic Diseases at the University Hospital of Strasbourg, Professor Jeandidier has more than 20 years’ experience in the field.
Prof. Jeandidier is also an expert member of the Management Board at the European Diabetes Research Centre (CEED), as well as a member of the Scientific Committee at Defymed and President of the Scientific Committee at EVADIAC.
Dr Samy Talha is a specialist in Cardiology at the Centre of Thoracic Pathologies, Department of Physiology and Functional Explorations, University Hospitals of Strasbourg. With his extensive expertise, Dr Talha is central to the integration of knowledge in cardiology into the E-care platform.
His involvement in clinical research is multidimensional with a focus on the origin of myocardial endocrine stimulation after heart transplantation, the clinical relevance of brain natriuretic peptide (BNP) levels after heart transplantation and the role of this marker in heart failure.
Dr Amir Hajjam el Hassani received his PhD in Computer Science from the Université de Haute Alsace (UHA) in 1990. He is currently associate Professor HDR at the Université de Technologie de Belfort-Montbéliard (UTBM) and Head of Software Engineering and Knowledge. He is Deputy Director of Nanomedicine Lab., Imagery & Therapeutics at the Université de Franche Comté (UFC) and Head of Knowledge Engineering and Decision Support. His research areas include data mining and machine learning for decision support in the field of e-Health.
He is member of the Editorial Board of four international journals and author of 3 books. He was Chair of the first international conference eTelemed’09 and advisory Chair for the following editions. He is a member of the Science Committee of several international conferences and also acts as expert to the Regional Innovation Agency (ARI), the National Scientific and Technical Research Council of Morocco (CNRST) and the French National Association for Research and Technology (ANRT).
Sylvie Erve is Director of CENTICH, French National Centre of Expertise funded by the CNSA (French National Health Fund for Autonomy) to accelerate the development and use of technologies for autonomy and health. Through CENTICH, she ensures the following missions: promoting activity dedicated to technology watch and technological diffusion with the management and development of projects, such as TECHNICOTHÈQUE (technical assistance and advice technologies lending library) or LENA (living laboratory); project engineering and provision of services for evaluation, advice, research and innovation (e-Health, adapted homes, connected homes, assistive technologies, etc.).
She also manages the innovation unit of the Mutualité Française d’Anjou Mayenne.
Quality policy
Management Commitment
Predimed technology is specialised in software publishing. With 6 years of experience, we have developed expertise in the field of e-Health and scientific projects.
A human-sized company focused on the well-being of its employees, Predimed is composed of a technical and administrative team supported by a Scientific Committee that work in synergy to ensure the excellence of our solutions.
Situated at the cross-roads of digital and medical technologies, our mission is to improve the quality of life of patients through our e-Health solutions. To this end, we are committed to:
Meeting our user’s requirements :
• By developing user-friendly solutions;
• By allowing them to play an active role in their health;
• By listening to them and regularly asking about their level of satisfaction;
Complying with the Code of Medical Ethics through :
• The development of solutions recognised and approved by medical experts to lessen the detrimental effects of various diseases;
• The anonymity of health data;
Continiously improve our solutions in technology as well as from a regulatory and medical point of view.
In line with our values, Management decided to implement a quality management system in accordance with European requirements for the development and marketing of medical devices (CE marking). This system is the result of a collaborative effort involving the whole Predimed technology team, ensures the optimum development of our solutions and our continuous improvement. This goal takes the form of target-setting for each process.
Every employee working at Predimed technology is required to comply with the company policy to ensure both their professional development and the success of the company.
Management undertakes to implement all the means and resources needed to apply this quality policy.
OUR PARTNERS
